Cumberland Pharmaceuticals (CPIX) Total Debt Growth (3y) (2015 - 2026)
Cumberland Pharmaceuticals (CPIX) Total Debt Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 92.83% |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.17% |
| Dec 31, 2025 | -31.35% |
| Sep 30, 2025 | -33.35% |
| Jun 30, 2025 | -34.91% |
| Mar 31, 2025 | -36.01% |
| Dec 31, 2024 | 0.61% |
| Sep 30, 2024 | 2.37% |
| Jun 30, 2024 | 4.75% |
| Mar 31, 2024 | 2.35% |
| Dec 31, 2023 | -5.19% |
| Sep 30, 2023 | -8.73% |
| Jun 30, 2023 | -8.21% |
| Mar 31, 2023 | -4.58% |
| Dec 31, 2022 | -4.33% |
| Sep 30, 2022 | -3.99% |
| Jun 30, 2022 | -1.70% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -9.14% |
| Sep 30, 2021 | 7.72% |
| Jun 30, 2021 | 5.27% |